Thrombin-activable fibrinolysis inhibitor (TAFI) zymogen is an active carboxypeptidase (Q33265163)

24 July 2017

Thrombin-activable fibrinolysis inhibitor (TAFI) zymogen is an active carboxypeptidase (English)

1 reference

24 July 2017

1 reference

Jan J Enghild

4

0 references

Jan Potempa

series ordinal

3

object named as

Jan Potempa

1 reference

24 July 2017

Zuzana Valnickova

1

1 reference

PubMed ID

17138567

24 July 2017

Ida B Thøgersen

series ordinal

2

1 reference

PubMed ID

17138567

24 July 2017

language of work or name

English

0 references

publication date

30 November 2006

1 reference

Journal of Biological Chemistry

24 July 2017

1 reference

24 July 2017

282

1 reference

24 July 2017

5

1 reference

24 July 2017

3066-3076

1 reference

Post-translational modifications of human thrombin-activatable fibrinolysis inhibitor (TAFI): evidence for a large shift in the isoelectric point and reduced solubility upon activation

24 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Purification and characterization of a new arginine carboxypeptidase in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Thrombin-activatable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Carboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Activated human plasma carboxypeptidase B is retained in the blood by binding to alpha2-macroglobulin and pregnancy zone protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Isolation and characterization of pancreatic procarboxypeptidase B and carboxypeptidase B of the African lungfish

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Characterisation and preliminary X-ray diffraction analysis of human pancreatic procarboxypeptidase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Human procarboxypeptidase B: three-dimensional structure and implications for thrombin-activatable fibrinolysis inhibitor (TAFI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

An examination of the inhibitory mechanism of serpins by analysing the interaction of trypsin and chymotrypsin with alpha 2-antiplasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Determination of the best-fit values of kinetic parameters of the Michaelis-Menten equation by the method of least squares with the Taylor expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

A carboxypeptidase inhibitor from the tick Rhipicephalus bursa: isolation, cDNA cloning, recombinant expression, and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Protein folding during cotranslational translocation in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Roles of N-linked glycans in the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

Expression of a synthetic gene encoding potato carboxypeptidase inhibitor using a bacterial secretion vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606559200

21 January 2018

Identifiers

DOI

10.1074/JBC.M606559200

1 reference

24 July 2017

1 reference

PubMed ID

17138567